Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Nordicus Partners Corporation (NORD)

Champions Oncology, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Champions Oncology, Inc. and Nordicus Partners Corporation are of similar size ($66.3M and $63.2M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −71.7%. Nordicus Partners Corporation has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (−4.43% vs −626.2%). Across the 17 metrics below, Nordicus Partners Corporation leads on 9 and Champions Oncology, Inc. on 8.

Valuation

Metric CSBR NORD Biotechnology median
P/E n/m n/m 10.60
P/S 1.10 77.00 9.40
P/B 14.96 1.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 200.80 n/m 0.66
EV/Sales 1.03 79.49 9.02
Earnings yield (1.67%) (8.70%) (32.88%)
Free cash flow yield (9.16%) (6.60%) (23.13%)

Profitability

Metric CSBR NORD Biotechnology median
Gross margin 49.82% 70.18% 68.51%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (8.06%) (51.96%)
Return on assets (3.56%) (6.80%) (46.06%)
Return on invested capital (626.23%) (4.43%) 0.00%

Growth

Metric CSBR NORD Biotechnology median
Revenue growth (TTM) 6.65% (71.68%) 6.76%
EPS growth (last fiscal year) (124.24%) 30.58% 29.88%
Revenue growth, 5-year CAGR 7.68% (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 0.18 4.97
Net debt to EBITDA (20.56) 0.00 1.01

Dividend

Metric CSBR NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR NORD Biotechnology median
Market cap 66.26m 63.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack